Malik Rajiv
Director at VTRS; President at Mylan N.V.; President at MYLAN LABORATORIES INC
- Sold, on record
- $52.3M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Sep 12, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- VTRSViatris IncDirector
- Mylan N.V.President
- MYLAN LABORATORIES INCPresident
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- VTRS949,960 shares
- MYLAN LABORATORIES INC929,923 shares
- Mylan N.V.75,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Mylan N.V.Plan not statedJun 9, 2017 2017
Sold 25,000 shares at $40.00 ($1M)
Malik Rajiv, President
Sold 3% of holdings ($33M position)799,855 shares leftFirst sale on recordFiling
- 2 Form 4 sale Mylan N.V.Plan not statedMar 2, 2018 +266 days
Sold 50,000 shares at $40.91 ($2M)
Malik Rajiv, President
Sold 9% of holdings ($22.7M position)503,751 shares leftFiling
- 3 Form 144 notice VTRSNoticeJun 13, 2024 +2295 days
Filed to sell 350,000 shares ($3.7M)
Malik Rajiv, Affiliate
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale VTRSUnusualJun 14, 2024 +1 day
Sold 349,960 shares at $10.26 ($3.6M)
Malik Rajiv, Director
No 10b5-1 planSold 35.2% of holdings ($10.2M position)645,519 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 144 notice VTRSNoticeAug 20, 2024 +67 days
Filed to sell 600,000 shares ($7.1M)
Malik Rajiv, Director
No 10b5-1 planFiling
- 6 Form 4 sale VTRSUnusualAug 23, 2024 +3 days
Sold 300,000 shares at $11.74 ($3.5M)
Malik Rajiv, Director
No 10b5-1 planSold 65.2% of holdings ($5.4M position)160,319 shares leftFollows a Form 144Filing
- 7 Form 4 sale VTRSUnusualAug 30, 2024 +7 days
Sold 100,000 shares at $11.95 ($1.2M)
Malik Rajiv, Director
No 10b5-1 planSold 62.4% of holdings ($1.9M position)60,319 shares leftFollows a Form 144Filing
- 8 Form 4 sale VTRSUnusualSep 12, 2024 +13 days
Sold 200,000 shares at $11.68 ($2.3M)
Malik Rajiv, Director
No 10b5-1 planSold 100% of holdings ($2.3M position)0 shares left0.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (20)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Sep 13, 2024 | VTRS | Director | Form 4 sale | 200,000 | $2.3M | 100.0% | Unusual | SEC |
| Aug 30, 2024 | Aug 30, 2024 | VTRS | Director | Form 4 sale | 100,000 | $1.2M | 62.4% | Unusual | SEC |
| Aug 23, 2024 | Aug 23, 2024 | VTRS | Director | Form 4 sale | 300,000 | $3.5M | 65.2% | Unusual | SEC |
| Aug 20, 2024 | Aug 20, 2024 | VTRS | Director | Form 144 notice | 600,000 | $7.1M | Notice | SEC | |
| Jun 14, 2024 | Jun 17, 2024 | VTRS | Director | Form 4 sale | 349,960 | $3.6M | 35.2% | Unusual | SEC |
| Jun 13, 2024 | Jun 13, 2024 | VTRS | Affiliate | Form 144 notice | 350,000 | $3.7M | Notice | SEC | |
| Mar 2, 2018 | Mar 6, 2018 | Mylan N.V. | President | Form 4 sale | 50,000 | $2M | 9.0% | Plan not stated | SEC |
| Jun 9, 2017 | Jun 9, 2017 | Mylan N.V. | President | Form 4 sale | 25,000 | $1M | 3.0% | Plan not stated | SEC |
| Feb 3, 2015 | Feb 3, 2015 | MYLAN LABORATORIES INC | President | Form 4 sale | 285,394 | $15.2M | 36.8% | Unusual | SEC |
| Nov 25, 2014 | Nov 26, 2014 | MYLAN LABORATORIES INC | President | Form 4 sale | 120,000 | $6.7M | 29.3% | Unusual | SEC |
| Apr 22, 2014 | Apr 24, 2014 | MYLAN LABORATORIES INC | President | Form 4 sale | 80,000 | $4M | 21.7% | Plan not stated | SEC |
| Dec 11, 2013 | Dec 13, 2013 | MYLAN LABORATORIES INC | President | Form 4 sale | 121,207 | $5.1M | 34.3% | Unusual | SEC |
| Dec 19, 2012 | Dec 21, 2012 | MYLAN LABORATORIES INC | President | Form 4 sale | 100,000 | $2.8M | 35.1% | Unusual | SEC |
| Aug 28, 2012 | Aug 29, 2012 | MYLAN LABORATORIES INC | President | Form 4 sale | 97,306 | $2.3M | 34.4% | Unusual | SEC |
| Mar 28, 2012 | Mar 29, 2012 | MYLAN LABORATORIES INC | President | Form 4 sale | 14,914 | $345k | 7.5% | Unusual | SEC |
| Mar 28, 2011 | Mar 28, 2011 | MYLAN LABORATORIES INC | EVP & Chief Operating Officer | Form 4 sale | 1,820 | $41k | 1.2% | Plan not stated | SEC |
| Mar 18, 2011 | Mar 21, 2011 | MYLAN LABORATORIES INC | EVP & Chief Operating Officer | Form 4 sale | 21,527 | $473k | 13.3% | Unusual | SEC |
| Mar 4, 2011 | Mar 4, 2011 | MYLAN LABORATORIES INC | EVP & Chief Operating Officer | Form 4 sale | 2,065 | $47k | 2.1% | Plan not stated | SEC |
| Mar 3, 2010 | Mar 5, 2010 | MYLAN LABORATORIES INC | Chief Operating Officer | Form 4 sale | 80,000 | $1.7M | 56.6% | Unusual | SEC |
| Mar 20, 2009 | Mar 20, 2009 | MYLAN LABORATORIES INC | Exec. VP, Global Tech. Ops. | Form 4 sale | 5,690 | $75k | 12.1% | Plan not stated | SEC |